Augusto Villanueva

机构：NYU Langone Health, Tisch Hospital, New York University, Icahn School of Medicine at Mount Sinai · ORCID：0000-0003-3585-3727

发表论文 389 篇 · 总被引 43129 次 · h-index 83

代表论文

• Current and emerging strategies for the prevention of hepatocellular carcinoma (2024 · Nature Reviews Gastroenterology & Hepatology · 被引 82)
• Hepatocellular carcinoma: Epidemiology, diagnosis and treatment (2025 · JHEP Reports · 被引 69)
• Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma (2024 · Journal of Hepatology · 被引 61)
• Author Correction: Hepatocellular carcinoma (2024 · Nature Reviews Disease Primers · 被引 48)
• Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside (2024 · Health Affairs Scholar · 被引 16)
• Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction–associated steatotic liver diseases: Target trial emulation using real-world data (2025 · Hepatology · 被引 15)